Neurokaire
1 known investors
NeuroKaire provides a diagnostic approach that evaluates how a patient's brain and body biology are likely to respond to different antidepressant medications before treatment begins, aiming to reduce trial-and-error in prescribing. It serves patients and healthcare providers as a tool to support antidepressant treatment selection.
Investors Β· 1
Frequently asked questions
- What does Neurokaire do?
- NeuroKaire provides a diagnostic approach that evaluates how a patient's brain and body biology are likely to respond to different antidepressant medications before treatment begins, aiming to reduce trial-and-error in prescribing. It serves patients and healthcare providers as a tool to support antidepressant treatment selection.
- Who are Neurokaire's investors?
- Neurokaire's investors include Meron Capital.